Trials / Completed
CompletedNCT01604239
To Evaluate the Safety of 'Shinbaro Capsule'in Patients With Osteoarthritis
A 24 Weeks, Multi-centers, Single Arm Phase IV Study to Evaluate the Safety of 'Shinbaro Capsule' Compared With Historical Data of 'Celebrex Capsule' in Patients With Osteoarthritis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 761 (actual)
- Sponsor
- Green Cross Corporation · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This study investigates if Shinbaro capsule has a lower incident of gastrointestinal events than celecoxib in subjects with osteoarthritis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Shinbaro Capsule | 600mg twice a day (b.i.d) oral herbal medicine |
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2013-06-01
- Completion
- 2013-06-01
- First posted
- 2012-05-23
- Last updated
- 2013-11-13
Locations
18 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01604239. Inclusion in this directory is not an endorsement.